Immunotherapy is the form of treatment that redirects the immune system toward a pathogen or disease. In many cases, ...
The addition of epcoritamab-bysp to standard chemotherapy significantly improved response and survival for patients with ...
The FDA has approved a new three-drug combination to treat certain types of an aggressive blood cancer called large B-cell lymphoma (LBCL).
Bristol Myers Squibb (BMS) has reported that the multi-centre Phase II TRANSCEND FL trial assessing its cluster of ...
Among adults with relapsed or refractory indolent B-cell non-Hodgkin lymphoma, the phase 2 TRANSCEND FL trial met its primary ...
News Medical on MSN1d
Unlocking the potential of double negative memory B cells in cancer treatmentUniversity of Pittsburgh School of Medicine and UPMC Hillman Cancer Center scientists have discovered a novel subset of cancer-fighting immune cells that reside outside of their normal neighborhood – ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback